nach oben

Erschienen in:

13.06.2020 | Neuro

Texture analysis in susceptibility-weighted imaging may be useful to differentiate acute from chronic multiple sclerosis lesions

verfasst von: Giovanni Caruana, Lucas M. Pessini, Roberto Cannella, Giuseppe Salvaggio, Andréa de Barros, Annalaura Salerno, Cristina Auger, Àlex Rovira

Erschienen in: European Radiology | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the diagnostic performance of texture analysis (TA) applied on non-contrast-enhanced susceptibility-weighted imaging (SWI) to differentiate acute (enhancing) from chronic (non-enhancing) multiple sclerosis (MS) lesions.

Methods

We analyzed 175 lesions from 58 patients with relapsing-remitting MS imaged on a 3.0 T MRI scanner and applied TA on T2-w and SWI images to extract texture features. We evaluated the presence or absence of lesion enhancement on T1-w post-contrast images and performed a computational statistical analysis to assess if there was any significant correlation between the texture features and the presence of lesion activity. ROC curves and leave-one-out cross-validation were used to evaluate the performance of individual features and multiparametric models in the identification of active lesions.

Results

Multiple TA features obtained from SWI images showed a significantly different distribution in acute and chronic lesions (AUC, 0.617–0.720). Multiparametric predictive models based on logistic ridge regression and partial least squares regression yielded an AUC of 0.778 and 0.808, respectively. Results from T2-w images did not show any significant predictive ability of neither individual features nor multiparametric models.

Conclusions

Texture analysis on SWI sequences may be useful to differentiate acute from chronic MS lesions. The good diagnostic performance could help to reduce the need of intravenous contrast agent administration in follow-up MRI studies.

Key Points

• Texture analysis applied on SWI sequences may be useful to differentiate acute from chronic multiple sclerosis lesions

• The good diagnostic performance could help to minimize the need of intravenous contrast agent administration in follow-up MRI studies

Nur mit Berechtigung zugänglich

Confavreux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability in multiple sclerosis. N Engl J Med 343:1430–1438CrossRef

Rovira À, León A (2008) MR in the diagnosis and monitoring of multiple sclerosis: an overview. Eur J Radiol 67:409–414CrossRef

Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173CrossRef

Choi JW, Moon W-J (2019) Gadolinium deposition in the brain: current updates. Korean J Radiol 20:134CrossRef

Zhang B, Liang L, Chen W, Liang C, Zhang S (2015) An updated study to determine association between gadolinium-based contrast agents and nephrogenic systemic fibrosis. PLoS One 10:e0129720CrossRef

Kutzelnigg A, Lassmann H (2014) Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handb Clin Neurol 122:15–58

Mehta V, Pei W, Yang G et al (2013) Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One 8:e57573CrossRef

Haacke EM, Makki M, Ge Y et al (2009) Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 29:537–544CrossRef

Zhang Y, Gauthier SA, Gupta A et al (2016) Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM). J Magn Reson Imaging 44:426–432CrossRef

10.

Chen W, Gauthier SA, Gupta A et al (2014) Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology 271:183–192CrossRef

11.

Lubner MG, Smith AD, Sandrasegaran K, Sahani DV, Pickhardt PJ (2017) CT texture analysis: definitions, applications, biologic correlates, and challenges. Radiographics 37:1483–1503CrossRef

12.

Cannella R, Rangaswamy B, Minervini MI, Borhani AA, Tsung A, Furlan A (2019) Value of texture analysis on gadoxetic acid–enhanced MRI for differentiating hepatocellular adenoma from focal nodular hyperplasia. AJR Am J Roentgenol 212:538–546CrossRef

13.

Yu O, Mauss Y, Zollner G, Namer I, Chambron J (1999) Distinct patterns of active and non-active plaques using texture analysis on brain NMR images in multiple sclerosis patients: preliminary results. Magn Reson Imaging 17:1261–1267CrossRef

14.

Michoux N, Guillet A, Rommel D, Mazzamuto G, Sindic C, Duprez T (2015) Texture analysis of T2-weighted MR images to assess acute inflammation in brain MS lesions. PLoS One 10:e0145497CrossRef

15.

Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRef

16.

Nioche C, Orlhac F, Boughdad S et al (2018) LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res 78:4786–4789CrossRef

17.

Orlhac F, Nioche C, Buvat I (2019) LIFEx texture user guide. https://www.lifexsoft.org/images/phocagallery/documentation/ProtocolTexture/UserGuide/TextureUserGuide.pdf

18.

Thissen D, Steinberg L, Kuang D (2002) Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons. J Educ Behav Stat 27:77–83CrossRef

19.

Wong T-T (2015) Performance evaluation of classification algorithms by k-fold and leave-one-out cross validation. Pattern Recognit 48:2839–2846CrossRef

20.

Gaitán MI, Shea CD, Evangelou IE et al (2011) Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol 70:22–29CrossRef

21.

Bagnato F, Hametner S, Yao B et al (2011) Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 134:3602–3615CrossRef

22.

Wisnieff C, Ramanan S, Olesik J, Gauthier S, Wang Y, Pitt D (2015) Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron. Magn Reson Med 74:564–570CrossRef

23.

Salem M, Cabezas M, Valverde S et al (2018) A supervised framework with intensity subtraction and deformation field features for the detection of new T2-w lesions in multiple sclerosis. NeuroImage Clin 17:607–615CrossRef

24.

Giambelluca D, Cannella R, Vernuccio F et al (2019) PI-RADS 3 lesions: role of prostate MRI texture analysis in the identification of prostate cancer. Curr Probl Diagn Radiol. https://doi.org/10.1067/j.cpradiol.2019.10.009

25.

Mahmoud-Ghoneim D, Toussaint G, Constans J-M, de Certaines JD (2003) Three dimensional texture analysis in MRI: a preliminary evaluation in gliomas. Magn Reson Imaging 21:983–987CrossRef

26.

Varghese BA, Cen SY, Hwang DH, Duddalwar VA (2019) Texture analysis of imaging: what radiologists need to know. AJR Am J Roentgenol 212:520–528CrossRef

Titel: Texture analysis in susceptibility-weighted imaging may be useful to differentiate acute from chronic multiple sclerosis lesions
verfasst von: Giovanni Caruana
Lucas M. Pessini
Roberto Cannella
Giuseppe Salvaggio
Andréa de Barros
Annalaura Salerno
Cristina Auger
Àlex Rovira
Publikationsdatum: 13.06.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 11/2020
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-020-06995-3

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Texture analysis in susceptibility-weighted imaging may be useful to differentiate acute from chronic multiple sclerosis lesions